Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1

Neuromuscular Disorders

Volumn 21, Issue 2, 2011, Pages 81-88

  Perbellini, Riccardo ^a,b   Greco, Simona ^a   Sarra Ferraris, Gianluca ^a   Cardani, Rosanna ^b   Capogrossi, Maurizio C ^c   Meola, Giovanni ^b   Martelli, Fabio ^c  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Gene expression; MicroRNAs; Myotonic dystrophy; Subcellular localization

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 206; MICRORNA 29B; MICRORNA 29C; MICRORNA 33; MICRORNA 335; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MYOTONIC DYSTROPHY; NEUROPATHOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; SKELETAL MUSCLE; TISSUE SPECIFICITY; UPREGULATION;

ADULT; BIOPSY; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DISORDERS; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASES; UP-REGULATION; YOUNG ADULT;

EID: 78751567960     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.11.012     Document Type: Article

References (35)

1. Turner C., Hilton-Jones D. The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 2010, 81(4):358-367.
2. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 799-808.
3. Fu Y.H., Pizzuti A., Fenwick R.G., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255(5049):1256-1258.
4. Mahadevan M., Tsilfidis C., Sabourin L., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255(5049):1253-1255.
5. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic Dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-868.
6. Johanna E., Lee, Cooper Thomas A Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009, 37:1281-1286.
7. Flynt A.S., Lai E.C. Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genetics 2008, 9(11):831-842.
8. Van Rooij E., Liu N., Olson E.N. MicroRNAs flex their muscles. Trends Genet 2008, 24(4):159-166.
9. Fasanaro P., Greco S., Ivan M., Capogrossi M.C., Martelli F. MicroRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 2010, 125(1):92-104.
10. Latronico M.V., Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 2009, 6(6):419-429.
11. Cardinali B., Castellani L., Fasanaro P., et al. Microrna-221 and microrna-222 modulate differentiation and maturation of skeletal muscle cells. PLoS One 2009, 4(10):e7607.
12. Naguibneva I., Ameyar-Zazoua M., Polesskaya A., et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 2006, 8(3):278-284.
13. Greco S., De Simone M., Colussi C., et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 2009, 23(10):3335-3346.
14. Eisenberg I., Alexander M.S., Kunkel L.M. MiRNAS in normal and diseased skeletal muscle. J Cell Mol Med 2009, 13(1):2-11.
15. Eisenberg I., Eran A., Nishino I., et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 2007, 104:17016-17021.
16. Gambardella S., Rinaldi F., Lepore S M., et al. Overexpression of microRNA-206 in the skeletal muscle from myotonc dystrophy type 1 patients. J Transl Med 2010, 8:48.
17. Moxley RT 3rd, Meola G, Udd B, Ricker K. Report of the 84th ENMC workshop: PROMM (proximal myotonic myopathy) and other myotonic dystrophy-like syndromes: 2nd workshop. 13-15th October, 2000, Loosdrecht, The Netherlands. Neuromuscul Disord 2002; 12(3): 306-17.
18. Cardani R., Mancinelli E., Sansone V., Rotondo G., Meola G. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 2004, 48(4):437-442.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
20. Vihola A., Bassez G., Meola G., et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60(11):1854-1857.
21. Yuasa K., Hagiwara Y., Ando M., Nakamura A., Takeda S., Hijikata T. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct Funct 2008, 33(2):163-169.
22. Parker R., Sheth U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007, 25(5):635-646.
23. Williams A.H., Liu N., van Rooij E., Olson E.N. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009, 21(3):461-469.
24. Hendrickson D.G., Hogan D.J., Herschlag D., Ferrell J.E., Brown P.O. Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance. PLoS One 2008, 3(5):e2126.
25. Murton A.J., Constantin D., Greenhaff P.L. The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008, 1782(12):730-743.
26. Tews D.S., Behrhof W., Schindler S. SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins. Appl Immunohistochem Mol Morphol 2008, 16(1):66-70.
27. Bergman E., Kullberg S., Ming Y., Ulfhake B. Upregulation of GFRalpha-1 and c-ret in primary sensory neurons and spinal motoneurons of aged rats. J Neurosci Res 1999, 57(2):153-165.
28. Hirose T., Nakazato K., Song H., Ishii N. TGF-beta1 and TNF-alpha are involved in the transcription of type I collagen alpha2 gene in soleus muscle atrophied by mechanical unloading. J Appl Physiol 2008, 104(1):170-177.
29. Van Rooij E., Sutherland L.B., Thatcher J.E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008, 105(35):13027-13032.
30. Latronico M.V., Condorelli G. MicroRNAs and cardiac conduction. Curr Drug Targets 2010, 11(8):907-912.
31. Luo X., Xiao J., Lin H., et al. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. Cell Physiol 2007, 212(2):358-367.
32. Yang B., Lin H., Xiao J., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13(4):486-491.
33. Ikeda S., He A., Kong S.W., et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 2009, 29(8):2193-2204.
34. Morlando M., Ballarino M., Gromak N., Pagano F., Bozzoni I., Proudfoot N.J. Primary microRNA transcripts are processed co-transcriptionally. Nat Struct Mol Biol 2008, 15(9):902-909.
35. Lee J.E., Cooper T.A. Pathogenic mechanisms of myotonic dystrophy. Biochem Soc Trans 2009, 37(Pt 6):1281-1286.